Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Net Cash Flow: 2017-2024

Historic Net Cash Flow for Kiniksa Pharmaceuticals International (KNSA) over the last 8 years, with Dec 2024 value amounting to $75.6 million.

  • Kiniksa Pharmaceuticals International's Net Cash Flow fell 806.54% to -$17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.5 million, marking a year-over-year increase of 478.85%. This contributed to the annual value of $75.6 million for FY2024, which is 612.34% up from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Net Cash Flow stood at $75.6 million for FY2024, which was up 612.34% from -$14.8 million recorded in FY2023.
  • Kiniksa Pharmaceuticals International's Net Cash Flow's 5-year high stood at $75.6 million during FY2024, with a 5-year trough of -$14.8 million in FY2023.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Net Cash Flow value was $245,000 (recorded in 2022), while the average stood at $20.4 million.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Net Cash Flow plummeted by 6,124.90% in 2023 and then spiked by 612.34% in 2024.
  • Yearly analysis of 5 years shows Kiniksa Pharmaceuticals International's Net Cash Flow stood at $67.1 million in 2020, then tumbled by 87.75% to $8.2 million in 2021, then slumped by 97.02% to $245,000 in 2022, then plummeted by 6,124.90% to -$14.8 million in 2023, then soared by 612.34% to $75.6 million in 2024.